64 related articles for article (PubMed ID: 22493387)
21. Optimal immunohistochemical markers for distinguishing lung adenocarcinomas from squamous cell carcinomas in small tumor samples.
Terry J; Leung S; Laskin J; Leslie KO; Gown AM; Ionescu DN
Am J Surg Pathol; 2010 Dec; 34(12):1805-11. PubMed ID: 21107086
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the expression levels of napsin A, thyroid transcription factor-1, and p63 in nonsmall cell lung cancer using cytocentrifuged bronchial brushings.
Aikawa E; Kawahara A; Hattori S; Yamaguchi T; Abe H; Taira T; Azuma K; Kage M
Cancer Cytopathol; 2011 Oct; 119(5):335-45. PubMed ID: 21717589
[TBL] [Abstract][Full Text] [Related]
23. Distribution of subtypes of metastatic renal-cell carcinoma: correlating findings of fine-needle aspiration biopsy and surgical pathology.
Mai KT; Alhalouly T; Lamba M; Yazdi HM; Stinson WA
Diagn Cytopathol; 2003 Feb; 28(2):66-70. PubMed ID: 12561022
[TBL] [Abstract][Full Text] [Related]
24. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.
Sugita M; Geraci M; Gao B; Powell RL; Hirsch FR; Johnson G; Lapadat R; Gabrielson E; Bremnes R; Bunn PA; Franklin WA
Cancer Res; 2002 Jul; 62(14):3971-9. PubMed ID: 12124329
[TBL] [Abstract][Full Text] [Related]
25. Cytologic, histologic and electron microscopic correlations in poorly differentiated primary lung carcinoma. A study of 43 cases.
Mennemeyer R; Hammar SP; Bauermeister DE; Wheelis RF; Jones HW; Bartha M
Acta Cytol; 1979; 23(4):297-302. PubMed ID: 231365
[TBL] [Abstract][Full Text] [Related]
26. Sarcomatoid carcinoma of the prostate: progression from adenocarcinoma is associated with p53 over-expression.
Delahunt B; Eble JN; Nacey JN; Grebe SK
Anticancer Res; 1999; 19(5B):4279-83. PubMed ID: 10628387
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical analysis of NANOG expression and epithelial-mesenchymal transition in pulmonary sarcomatoid carcinoma.
Tamaki T; Shimizu T; Niki M; Shimizu M; Nishizawa T; Nomura S
Oncol Lett; 2017 May; 13(5):3695-3702. PubMed ID: 28529586
[TBL] [Abstract][Full Text] [Related]
28. Integrin-linked kinase pathway in heterogeneous pulmonary sarcomatoid carcinoma.
Shimizu S; Sakai K; Chikugo T; Satou T; Shiraishi N; Mitsudomi T; Nishio K
Oncol Lett; 2021 Apr; 21(4):320. PubMed ID: 33692852
[TBL] [Abstract][Full Text] [Related]
29. Pulmonary sarcomatoid carcinoma in a renal transplant recipient.
Basic-Jukic N; Kes P
Transplant Proc; 2015 Apr; 47(3):834-5. PubMed ID: 25724254
[TBL] [Abstract][Full Text] [Related]
30. The Correlation Between Histologic, Immunophenotypic, and Molecular Characteristics of Pulmonary Sarcomatoid Carcinoma Reveals That Sarcomatoid Change Is Potentially Derived From Epithelial Carcinoma Cells Undergoing Epithelial-Mesenchymal Transition.
Huang Y; Guo J; Li S; Liu J; Xu J; Ye W; Zhang L; Dong Z; Wu W; Wu C; Hou L
Appl Immunohistochem Mol Morphol; 2023 Jan; 31(1):17-25. PubMed ID: 36165833
[TBL] [Abstract][Full Text] [Related]
31. Pulmonary Carcinosarcoma: A Rare Disease With Challenging Diagnosis and Treatment.
Mekheal E; Kapoor A; Roman S; Mekheal N; Millet C; Mekheal M; Maroules M
Cureus; 2022 Jul; 14(7):e26901. PubMed ID: 35983399
[TBL] [Abstract][Full Text] [Related]
32. Pleomorphic carcinoma of the lung mimicking synchronous pulmonary adenocarcinoma and small bowel sarcoma.
Kim MJ; Lee HN; Kim JI; Kim GY
Ann Thorac Med; 2018; 13(4):251-253. PubMed ID: 30416598
[TBL] [Abstract][Full Text] [Related]
33. Pten and p53 Loss in the Mouse Lung Causes Adenocarcinoma and Sarcomatoid Carcinoma.
Lázaro S; Lorz C; Enguita AB; Seller I; Paramio JM; Santos M
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954335
[TBL] [Abstract][Full Text] [Related]
34. Biological characteristics and clinical treatment of pulmonary sarcomatoid carcinoma: a narrative review.
Wei Y; Wang L; Jin Z; Jia Q; Brcic L; Akaba T; Chu Q
Transl Lung Cancer Res; 2024 Mar; 13(3):635-653. PubMed ID: 38601447
[TBL] [Abstract][Full Text] [Related]
35. Approaches to Tumor Classification in Pulmonary Sarcomatoid Carcinoma.
Baldovini C; Rossi G; Ciarrocchi A
Lung Cancer (Auckl); 2019; 10():131-149. PubMed ID: 31824199
[TBL] [Abstract][Full Text] [Related]
36. [Current Status of Diagnosis and Treatment of Pulmonary Sarcomatoid Carcinoma].
Liu L; Zang R; Song P; Gao S
Zhongguo Fei Ai Za Zhi; 2018 Dec; 21(12):902-906. PubMed ID: 30591097
[TBL] [Abstract][Full Text] [Related]
37. Serological Assessment of Activated Fibroblasts by alpha-Smooth Muscle Actin (α-SMA): A Noninvasive Biomarker of Activated Fibroblasts in Lung Disorders.
Holm Nielsen S; Willumsen N; Leeming DJ; Daniels SJ; Brix S; Karsdal MA; Genovese F; Nielsen MJ
Transl Oncol; 2019 Feb; 12(2):368-374. PubMed ID: 30504086
[TBL] [Abstract][Full Text] [Related]
38. Quantification of altered tissue turnover in a liquid biopsy: a proposed precision medicine tool to assess chronic inflammation and desmoplasia associated with a pro-cancerous niche and response to immuno-therapeutic anti-tumor modalities.
Willumsen N; Thomsen LB; Bager CL; Jensen C; Karsdal MA
Cancer Immunol Immunother; 2018 Jan; 67(1):1-12. PubMed ID: 29022089
[TBL] [Abstract][Full Text] [Related]
39. Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness.
Moro M; Bertolini G; Caserini R; Borzi C; Boeri M; Fabbri A; Leone G; Gasparini P; Galeone C; Pelosi G; Roz L; Sozzi G; Pastorino U
Sci Rep; 2017 Jul; 7(1):6689. PubMed ID: 28751748
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
